CRIS Current Research Information System

PALAZZINI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.241
AS - Asia 5.146
EU - Europa 3.648
AF - Africa 340
SA - Sud America 306
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.692
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.166
VN - Vietnam 1.583
SG - Singapore 1.325
CN - Cina 1.185
IT - Italia 911
GB - Regno Unito 773
DE - Germania 414
HK - Hong Kong 377
SE - Svezia 284
FR - Francia 264
UA - Ucraina 208
BR - Brasile 207
IN - India 194
IE - Irlanda 182
RU - Federazione Russa 165
NL - Olanda 119
CI - Costa d'Avorio 113
FI - Finlandia 88
KR - Corea 87
ZA - Sudafrica 84
JP - Giappone 73
TG - Togo 72
EE - Estonia 59
JO - Giordania 51
CA - Canada 48
PH - Filippine 42
AR - Argentina 38
TH - Thailandia 35
BG - Bulgaria 31
ID - Indonesia 30
AT - Austria 26
TR - Turchia 25
BE - Belgio 23
BD - Bangladesh 22
SC - Seychelles 21
PL - Polonia 20
PK - Pakistan 19
CH - Svizzera 18
IR - Iran 18
TW - Taiwan 18
CO - Colombia 17
EC - Ecuador 17
IQ - Iraq 17
MX - Messico 15
ES - Italia 12
NG - Nigeria 12
GR - Grecia 10
UZ - Uzbekistan 10
EG - Egitto 9
AU - Australia 7
PY - Paraguay 7
SA - Arabia Saudita 7
VE - Venezuela 7
AL - Albania 6
CL - Cile 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
MA - Marocco 5
MY - Malesia 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
KE - Kenya 4
LB - Libano 4
PE - Perù 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
MK - Macedonia 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
GH - Ghana 2
HU - Ungheria 2
MT - Malta 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BY - Bielorussia 1
CD - Congo 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MW - Malawi 1
MZ - Mozambico 1
Totale 14.686
Salva come PNG Salva come JPEG
Città #
Singapore 871
Southend 677
Ashburn 528
Chandler 513
Fairfield 501
Hong Kong 360
Ho Chi Minh City 323
Hanoi 295
Santa Clara 281
San Jose 256
Wilmington 246
Woodbridge 240
Dong Ket 197
Beijing 196
Houston 189
Dublin 181
Seattle 181
Princeton 180
Cambridge 172
Ann Arbor 156
Hefei 156
Bologna 148
Boardman 114
Abidjan 113
Lauterbourg 97
Jacksonville 93
Milan 89
Padova 78
Nanjing 75
Westminster 74
Lomé 72
Los Angeles 69
Seoul 69
Helsinki 67
Tokyo 65
Turin 63
Amman 51
Berlin 51
Buffalo 48
New York 47
Haiphong 45
Da Nang 44
Jinan 40
Shenyang 40
San Diego 35
Council Bluffs 34
Guangzhou 34
Medford 30
Dallas 29
Saint Petersburg 29
Sofia 29
Rome 28
Hebei 27
Redondo Beach 27
Jiaxing 26
Changsha 24
Des Moines 24
Brussels 23
Nanchang 23
Munich 22
São Paulo 22
Shanghai 20
Hangzhou 19
Bengaluru 18
Mülheim 18
Montreal 17
Dearborn 16
London 16
Toronto 16
Yubileyny 16
Zhengzhou 16
Can Tho 15
Chicago 15
Falls Church 15
Florence 15
Frankfurt am Main 15
Tianjin 15
Vienna 15
Amsterdam 14
Olalla 14
Warsaw 14
Chengdu 13
Johannesburg 13
Nuremberg 13
Paris 13
Biên Hòa 12
Falkenstein 12
Jakarta 12
Ninh Bình 12
Redmond 12
Taizhou 12
Abeokuta 11
Bern 11
Genoa 11
Lappeenranta 11
Mahé 11
Orem 11
The Dalles 11
Bremen 10
Ningbo 10
Totale 9.357
Salva come PNG Salva come JPEG
Nome #
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 262
A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 260
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 256
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 251
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 242
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 240
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 230
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 229
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 229
Pulmonary Arterial Hypertension associated to connective tissue diseases 221
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 220
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 209
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 205
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 204
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 199
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 198
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 193
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 193
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 188
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 187
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 182
Anticoagulant treatment in patients with pulmonary arterial hypertension associated with systemic sclerosis: More shadows than lights 177
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 177
Current therapeutic approaches to pulmonary arterial hypertension. 174
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 173
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 171
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 170
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 169
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 168
Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension 166
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 166
Sildenafil therapy in patients with porto-pulmonary hypertension 163
Challenges in pulmonary hypertension: Managing the unexpected 162
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 159
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 157
Cardiologia pediatrica. Problematiche cliniche 157
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 155
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 155
Rare causes of pulmonary hypertension. Spectrum of radiological findings and review of the literature 155
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study 154
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 153
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. 152
Pulmonary veno-occlusive disease: the role of CT 150
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 147
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 146
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 145
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 142
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 141
Pulmonary hypertension due to left heart disease 141
Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography. 140
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 140
[Treatment goals of pulmonary hypertension]. 139
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 139
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 139
Chronic thromboembolic pulmonary disease 138
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function 136
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 135
The difficult diagnosis of pulmonary vascular disease in heart failure 135
Long-term therapeutic outcomes in pulmonary arterial hypertension 133
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 133
Conventional Medical Therapies in the treatment of pulmonary hypertension 132
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 131
Epidemiology of patients referred to a specialised pulmonary hypertension center 130
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 130
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 129
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 128
The burden of comorbidities in pulmonary arterial hypertension 127
Current medical therapies in pulmonary arterial hypertension 126
Evidence for Kaposi's sarcoma-associated herpes virus infection in patients with idiopathic pulmonary arterial hypertension: a case series and review of the literature 124
Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension 124
Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting 124
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 124
Experience with inheritable pulmonary arterial hypertension in a specialised center 123
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 121
Pulmonary vascular disease due to left heart disease: How to achieve a more accurate approach beyond the haemodynamic phenotype: Reply 120
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 119
Balloon pulmonary angioplasty after pulmonary thromboendarterectomy 119
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 118
Long-term outcomes after pulmonary endarterectomy 118
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial 117
Pulmonary hypertension 116
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 114
Pulmonary artery intimal sarcoma. Problems in the differential diagnosis. I sarcomi intimali dell'arteria polmonare. Problemi di diagnosi differenziale 111
Left ventricular dimensions in pulmonary arterial hypertension: haemodynamic and exercise correlations 110
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism 109
Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: Still waiting for solid evidence 109
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 102
Pulmonary Hypertension: Lessons from Adults 102
Treatment goals of pulmonary hypertension. 101
Progressi nel trattamento delle malattie della circolazione polmonare 98
Left main coronary artery extrinsic compression by enlarged pulmonary artery in patients with pulmonary arterial hypertension 87
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 84
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 82
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 78
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2 76
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 75
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 68
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 65
Influence of age in the assessment of therapeutic response in patients with pulmonary arterial hypertension 58
Severe Precapillary Pulmonary Hypertension Due to Whipple Disease 56
Totale 14.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.495
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021557 0 0 0 0 0 0 0 0 0 54 47 456
2021/20221.603 139 80 106 134 123 88 43 100 62 118 303 307
2022/20232.045 202 275 94 266 94 171 62 115 416 96 146 108
2023/2024411 36 78 30 43 29 56 23 12 12 33 34 25
2024/20252.346 79 384 259 162 396 105 166 89 42 151 82 431
2025/20264.681 413 463 398 321 582 279 530 154 1.186 355 0 0
Totale 14.993